GS
TGTX icon

GWN Securities’s TG Therapeutics TGTX Stock Holding History

GWN Securities’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Sell
23,613
-1,112
-4% -$45.5K 0.22% 123
2026
Q1 		$821K Hold
24,725
– – 0.16% 163
2025
Q4 		$737K Buy
24,725
+3,543
+17% +$116K 0.15% 169
2025
Q3 		$765K Sell
21,182
-32,592
-61% -$1.07M 0.18% 142
2025
Q2 		$1.94M Buy
53,774
+26,884
+100% +$1M 0.36% 70
2025
Q1 		$1.06M Buy
26,890
+13,763
+105% +$463K 0.06% 295
2024
Q4 		$395K Buy
+13,127
New +$377K 0.11% 196

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

GWN Securities's TGTX Position: Q2 2026 in Review

GWN Securities reduced its TG Therapeutics (TGTX) stake by 4.5% in Q2 2026, selling an estimated $45.5K and leaving 23,613 shares worth $1.3M. The position accounts for 0.22% of the portfolio, ranked #123.

GWN Securities first reported a position in TGTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.94M in Q2 2025. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • GWN Securities held 23,613 shares of TG Therapeutics worth $1.3M as of Q2 2026.
  • GWN Securities sold 1,112 TG Therapeutics shares in Q2 2026, an estimated $45.5K.
  • TG Therapeutics made up 0.22% of GWN Securities's portfolio in Q2 2026, its #123 holding.
  • GWN Securities first reported a position in TG Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • GWN Securities's TG Therapeutics position peaked at $1.94M in Q2 2025.
  • 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on GWN Securities's 13F filing for Q2 2026, filed 5 Aug 2026.